Hello, shall i allways have zometa and herceptin (trastuzumab) for her 2 breast cancer bone metastasis? or, is zometa with femara enough? thanks a lot

Her2-pos Breast Ca: Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC. Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.